1  plasma or following placement or removal of venous lines.

2 ity in 8 of 27 patients (29.6%) with central venous lines.

3 Twenty-seven patients with permanent central venous lines (13 men and 14 women; mean age +/- SD, 53.8

4                                 Arterial and venous lines, a peritoneal catheter, and a rectal temper

5 Cardiac pacemakers and reservoirs of central venous lines can induce artifactual (18)F-FDG on CT-corr

6 ed after injection through the right central venous line confirmed the presence of a clot in the supe

7 e field of pediatrics often requires central venous line (CVC - Central Venous Catheter) implantation

8 leukemia (ALL), the optimal time for central venous line (CVL) insertion and the optimal type of CVL

9 e, prolonged immobility, presence of central venous lines, estrogens, and a wide variety of inherited

10  CI: 0.72 to 0.99, p = 0.04), use of central venous lines for >10 days or until hospital discharge (H

11  associated with the use of tunneled central venous lines in immunocompromised children and would sav

12 nsive care unit within 28 days after central venous line insertion) (9.8 +/- 9.9 days vs. 17.9 +/- 5.

13 hing unassisted within 28 days after central venous line insertion) compared with matched control pat

14 ys in the intensive care unit before central venous line insertion.

15 strogen state (P = .002), indwelling central venous line (P < .001), and prior PE and/or deep venous

16          The presence of symptomatic central venous line-related deep vein thrombosis is associated w

17                                      Central venous lines were introduced into right external jugular